SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing TCAR and carotid endarterectomy (CEA) have been published in Annals of Surgery1.
“These results continue to show low in-hospital stroke, death, and combined stroke/death rates as well as statistically lower rates of in-hospital cranial nerve injury and in-hospital myocardial infarction compared to CEA,” said Dr. Mahmoud Malas, Chief of Vascular and Endovascular surgery at UC San Diego Health. “These promising outcomes will likely increase the role of TCAR in the management of carotid artery stenosis.”
Read More: https://www.globenewswire.com/news-release/2020/09/21/2096566/0/en/Compelling-Outcomes-with-TCAR-vs-CEA-in-Patients-with-Carotid-Artery-Stenosis-Published-in-the-Annals-of-Surgery.html
Compelling Outcomes with TCAR vs. CEA in Patients with Carotid Artery Stenosis Published in the Annals of Surgery